ONCOLOGY

CARDIOTOXICITY & ARTA IN PROSTATE CANCER : Uncovering the underrecognized risk? 

Prostate cancer therapies are evolving rapidly – but what about their long-term cardiovascular impact? In this session, experts will explore the often-overlooked risks of ARTA treatments. An essential session for clinicians focused on long-term prostate cancer care.

🎓 Complete all videos and submit the short feedback forms to unlock your certificate.

Moderator:

Dr Berlinde von Kemp, UZ Brussel

Expert panel:

Prof Lucas Van Aelst, UZ Leuven
Dr Ruben De Wilde, UZ Brussel

Programme:

20:00 - 20:05 - Introduction - Prof Dr Guy Brusselle
20:05 - 20:20 - Highlights of ATS 2025: asthma - Prof Dr Guy Brusselle
20:20 - 20:25 - Q&A
20:25 - 20:40 - Highlights of ATS 2025 in the treatment of COPD - Prof Dr Marie Bruyneel
20:40 - 20:45 - Q&A
20:45 - 21:00 - Highlights of ATS 2025 in the treatment of ILD - Prof Dr Wim Wuyts
21:00 - 21:05 - Q&A
21:05 - 21:20 - Highlights of ATS 2025 in the treatment of respiratory infections - Prof Dr Pascal Van Bleyenbergh
21:20 - 21:25 - Q&A
21:25 - 21:30 - Closing - Prof Dr Guy Brusselle

ONCOLOGY

CARDIOTOXICITY & ARTA IN PROSTATE CANCER : Uncovering the underrecognized risk? 

Prostate cancer therapies are evolving rapidly – but what about their long-term cardiovascular impact? In this session, experts will explore the often-overlooked risks of ARTA treatments. An essential session for clinicians focused on long-term prostate cancer care.

Moderator:
Dr Berlinde von Kemp, UZ Brussel


Expert panel:
Prof Lucas Van Aelst, UZ Leuven
Dr Ruben De Wilde, UZ Brussel

Register via the form on the right to get free access to the videos. 👉

This course is currently available for physicians only.

Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.